Welcome to LookChem.com Sign In|Join Free

CAS

  • or

81246-79-9

Post Buying Request

81246-79-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

81246-79-9 Usage

Description

5'-O-(4,4'-Dimethoxytrityl)uridine is a nucleoside derivative of uridine, which is a component of RNA. 5'-O-(4,4'-Dimethoxytrityl)uridine is characterized by the presence of a trityl protecting group on the 5' hydroxyl group of the uridine molecule. It plays a crucial role in the synthesis of nucleic acids and serves as a key building block in the assembly of oligonucleotides. The trityl group in 5'-O-(4,4'-Dimethoxytrityl)uridine allows for selective removal during chemical synthesis, making it an essential intermediate for the production of modified nucleosides and nucleotides. These modified molecules are widely utilized in research, diagnostics, and therapeutics within the realm of molecular biology and biotechnology.

Uses

Used in Molecular Biology Research:
5'-O-(4,4'-Dimethoxytrityl)uridine is used as a building block for the synthesis of nucleic acids, particularly in the creation of oligonucleotides. Its trityl protecting group facilitates controlled and selective deprotection during the synthesis process, enabling the precise assembly of desired sequences.
Used in Diagnostic Applications:
In the field of diagnostics, 5'-O-(4,4'-Dimethoxytrityl)uridine serves as an intermediate for the production of modified nucleosides and nucleotides that are incorporated into diagnostic probes and assays. These modified molecules enhance the specificity, sensitivity, and stability of diagnostic tools, improving the accuracy of disease detection and monitoring.
Used in Therapeutic Applications:
5'-O-(4,4'-Dimethoxytrityl)uridine is utilized as a precursor in the development of modified nucleosides and nucleotides for therapeutic purposes. These modified molecules can be designed to target specific genetic sequences or pathways, offering potential treatments for various diseases, including viral infections and genetic disorders.
Used in Biotechnological Applications:
In biotechnology, 5'-O-(4,4'-Dimethoxytrityl)uridine is employed as a key component in the synthesis of engineered nucleic acids with novel properties. These engineered molecules can be used for various applications, such as the development of biosensors, the construction of artificial genetic systems, and the creation of RNA-based therapeutics.
Used in Pharmaceutical Industry:
5'-O-(4,4'-Dimethoxytrityl)uridine is used as an intermediate in the synthesis of modified nucleosides and nucleotides that serve as active pharmaceutical ingredients. These modified molecules can exhibit enhanced pharmacological properties, such as improved stability, targeted delivery, and reduced toxicity, leading to the development of more effective and safer drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 81246-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,2,4 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 81246-79:
(7*8)+(6*1)+(5*2)+(4*4)+(3*6)+(2*7)+(1*9)=129
129 % 10 = 9
So 81246-79-9 is a valid CAS Registry Number.

81246-79-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5'-O-(4,4'-Dimethoxytrityl)uridine

1.2 Other means of identification

Product number -
Other names 5'-DMTr-uridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:81246-79-9 SDS

81246-79-9Relevant articles and documents

Synthesis, Structural, and Conformational Analysis of 4′-C-Alkyl-2′-O-Ethyl-Uridine Modified Nucleosides

Nikam, Rahul R.,Harikrishna,Gore, Kiran R.

, p. 924 - 932 (2021/02/01)

Sugar modifications have attracted much attention due to their potential structural and functional influence on therapeutic nucleic acids. Herein, we report the synthesis of dual modified 4′-C-azidomethyl-2′-O-ethyl-uridine (4′-AzM-2′-OEt?U) and 4′-C-aminomethyl-2′-O-ethyl-uridine (4′-AM-2′-OEt?U) nucleosides using linear multi-step synthesis (16 linear steps). Additionally, we report an alternative route for the synthesis of 2′-O-ethyl-uridine nucleoside which has been achieved in three steps with an overall yield of 40 %. X-ray structure of 4′-AzM-2′-OEt?U illustrates that the nucleoside adopts C2′-endo (South) conformation having a DNA-type glycosidic bond (χ) angle of ?116.01°. Computational studies revealed the C2′-endo and C4′-exo conformations for 4′-AzM-2′-OEt?U and 4′-AM-2′-OEt?U free nucleosides, respectively. The C4′-exo conformation in 4′-AM-2′-OEt?U free nucleoside is collectively stabilized by various non-covalent interactions between positively charged aminomethyl and 2′,3′-hydroxyl groups. Insights into the structural and conformational analysis of dual sugar modified nucleosides and oligonucleotides will be helpful in the rational design of modified nucleosides and therapeutic oligonucleotides.

Azido Functionalized Nucleosides Linked to Controlled Pore Glass as Suitable Starting Materials for Oligonucleotide Synthesis by the Phosphoramidite Approach

Müggenburg, Frederik,Biallas, Alexander,Debiais, Mégane,Smietana, Michael,Müller, Sabine

, p. 6408 - 6416 (2021/11/30)

It has long been debated whether easily reducible azide groups can withstand the conditions of oligonucleotide synthesis by phosphoramidite chemistry. We have synthesized various 2′- and 3′-azido modified nucleosides and immobilized them on controlled pore glass (CPG) to be used as starting material for the synthesis of oligonucleotides (ONs) with 3′-terminal azide (attached to C2′ or C3′). In a model study, immobilized 3′-azidoadenosine was used as a starting block for the synthesis of a series of oligodeoxynucleotides (ODNs) of increasing length. Upon synthesis, the ODNs were enzymatically digested into monomers and analyzed by RP-HPLC. A peak corresponding to 3′-azidoadenosine was clearly identified in all samples. Quantitative analysis showed that 3′-azidoadenosine was present in nearly the expected ratio to deoxycytidine, which was used as an internal standard. Most importantly, the ratio remained the same for all three ODNs regardless of their length, demonstrating that a higher number of coupling cycles does not lead to higher degradation of the azide. Thus, 2′- or 3′-azido nucleosides attached to a solid support are excellent starting materials for the synthesis of oligonucleotides with 3′-terminal azide.

UNA AMIDITES AND USES THEREOF

-

Paragraph 0343; 0347, (2020/12/29)

Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a disease which utilize a composition or

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 81246-79-9